For years, it was a topic that would surface in studies and headlines, but rarely beyond. Then several countries began to get serious, requiring companies to report differences in gender pay gaps or trying to close it themselves. A few big firms spent millions trying to make up the pay difference between men and women in the same job. Read more here.
Wednesday, October 24, 2018
Korn Ferry: Picketing for Equal Pay
For years, it was a topic that would surface in studies and headlines, but rarely beyond. Then several countries began to get serious, requiring companies to report differences in gender pay gaps or trying to close it themselves. A few big firms spent millions trying to make up the pay difference between men and women in the same job. Read more here.
Sunday, October 21, 2018
Forbes Russia: Time to Bet on Putin
Санкции против Ирана, который скоро будут введены, а также невысокие котировки будут способствовать повышению стоимости акций российских компаний в краткосрочной перспективе. Хотя это ралли может продлиться недолго, там тем не менее существует возможность получить некоторое количество легких денег.
Read more here.
Friday, October 19, 2018
Barron's: It’s Time to Bet on British Stocks — Even With Brexit Looming
Wednesday, October 17, 2018
Forbes: Time To Bet On Putin?
By SIMON CONSTABLE
Love him or hate him, now might be the time to place a bet on Russian President Vladimir Putin.
Not exactly him, but rather the Russian stock market. Read more here.
SFS: Borrowing and Business -- What You Don't Know Can Hurt Your Finances
By SIMON CONSTABLE
So, you’re feeling confident enough about your business to go shopping for a loan.
Congratulations! But before you start looking you should understand these five important areas impacting loans, beginning with the difference between interest rates and APR. Read more here.
Korn Ferry: Has Brexit Hit the Disaster-Prepping Phase?
Friday, October 12, 2018
Barron's: Bayer Battling Back Against Legal Woes
By SIMON CONSTABLE
Shares of struggling German health-care and chemical giant Bayer revived a bit on Thursday as the company got at least a temporary reprieve from a huge jury award that held its weed killer Roundup liable for a plaintiff’s cancer.
There is likely to be more positive news for long-term investors, as this and related cases against Roundup proceed through the court system. Read more here.